Potency Meets Precision in Nano-optimized Chemotherapeutics

Artavazd Arumov, Asaad Trabolsi, Jonathan H. Schatz

Research output: Contribution to journalShort surveypeer-review

Abstract

Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.

Original languageEnglish (US)
JournalTrends in Biotechnology
DOIs
StateAccepted/In press - 2021

Keywords

  • cancer
  • drug delivery
  • lymphoma
  • nanotechnology
  • precision medicine
  • therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering

Fingerprint Dive into the research topics of 'Potency Meets Precision in Nano-optimized Chemotherapeutics'. Together they form a unique fingerprint.

Cite this